[go: up one dir, main page]

IT1241395B - Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria - Google Patents

Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria

Info

Publication number
IT1241395B
IT1241395B IT19914A IT1991490A IT1241395B IT 1241395 B IT1241395 B IT 1241395B IT 19914 A IT19914 A IT 19914A IT 1991490 A IT1991490 A IT 1991490A IT 1241395 B IT1241395 B IT 1241395B
Authority
IT
Italy
Prior art keywords
amino acid
lysine
acid residue
chem
vaccines
Prior art date
Application number
IT19914A
Other languages
English (en)
Other versions
IT9019914A0 (it
IT9019914A1 (it
Inventor
Antonello Pessi
Elisabetta Bianchi
Giampietro Corradin
Original Assignee
Eniricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa filed Critical Eniricerche Spa
Priority to IT19914A priority Critical patent/IT1241395B/it
Publication of IT9019914A0 publication Critical patent/IT9019914A0/it
Priority to AT91200727T priority patent/ATE131830T1/de
Priority to DK91200727.5T priority patent/DK0450715T3/da
Priority to DE69115539T priority patent/DE69115539T2/de
Priority to EP91200727A priority patent/EP0450715B1/en
Priority to ES91200727T priority patent/ES2082109T3/es
Publication of IT9019914A1 publication Critical patent/IT9019914A1/it
Application granted granted Critical
Publication of IT1241395B publication Critical patent/IT1241395B/it
Priority to GR960400139T priority patent/GR3018750T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT19914A 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria IT1241395B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT19914A IT1241395B (it) 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
AT91200727T ATE131830T1 (de) 1990-04-02 1991-03-28 Immunologische komponente, verfahren zur synthese und verwendung in anit-malaria-impfstoff- zusammensetzungen
DK91200727.5T DK0450715T3 (da) 1990-04-02 1991-03-28 Immunologiske forbindelser, en fremgangsmåde til fremstilling deraf og anvendelse deraf, ved fremstillingen af antimalaria-vacciner
DE69115539T DE69115539T2 (de) 1990-04-02 1991-03-28 Immunologische Komponente, Verfahren zur Synthese und Verwendung in Anit-Malaria-Impfstoff-Zusammensetzungen
EP91200727A EP0450715B1 (en) 1990-04-02 1991-03-28 Immunogenic compounds, the process for their synthesis and their use in the preparation of antimalaria vaccines
ES91200727T ES2082109T3 (es) 1990-04-02 1991-03-28 Compuestos inmunogenicos, el procedimiento para su sintesis y su uso en la preparacion de vacunas antimalaria.
GR960400139T GR3018750T3 (en) 1990-04-02 1996-01-19 Immunogenic compounds, the process for their synthesis and their use in the preparation of antimalaria vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19914A IT1241395B (it) 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria

Publications (3)

Publication Number Publication Date
IT9019914A0 IT9019914A0 (it) 1990-04-02
IT9019914A1 IT9019914A1 (it) 1991-10-02
IT1241395B true IT1241395B (it) 1994-01-10

Family

ID=11162291

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19914A IT1241395B (it) 1990-04-02 1990-04-02 Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria

Country Status (7)

Country Link
EP (1) EP0450715B1 (it)
AT (1) ATE131830T1 (it)
DE (1) DE69115539T2 (it)
DK (1) DK0450715T3 (it)
ES (1) ES2082109T3 (it)
GR (1) GR3018750T3 (it)
IT (1) IT1241395B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107434D0 (en) * 1991-04-09 1991-05-22 Medical Res Council Peptide-based assay
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
CA2499625A1 (en) 2002-09-18 2004-04-01 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
CN1871022B (zh) 2003-08-28 2011-07-06 奥索-麦克尼尔药品公司 结合血小板生成素受体的肽和化合物
CN102153654B (zh) * 2009-12-31 2012-10-10 中国疾病预防控制中心病毒病预防控制所 以免疫活性肽为载体的分支多肽及其衍生物与应用
EP2976325B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of cyclic imide containing peptide products
HK1219477A1 (zh) 2013-03-21 2017-04-07 Sanofi-Aventis Deutschland Gmbh 合成含有乙内酰脲的肽产物
US10583184B2 (en) 2014-11-28 2020-03-10 Shigeyuki Kano Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
ES2052517T3 (es) * 1986-07-16 1994-07-16 Eniricerche Spa Analogos de tuftsina parcialmente retroinversos, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
CA2006700A1 (en) * 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
CA2031197A1 (en) * 1989-04-12 1990-10-13 James P. Tam Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine

Also Published As

Publication number Publication date
ES2082109T3 (es) 1996-03-16
IT9019914A0 (it) 1990-04-02
ATE131830T1 (de) 1996-01-15
IT9019914A1 (it) 1991-10-02
EP0450715B1 (en) 1995-12-20
GR3018750T3 (en) 1996-04-30
DE69115539D1 (de) 1996-02-01
DK0450715T3 (da) 1996-02-26
EP0450715A1 (en) 1991-10-09
DE69115539T2 (de) 1996-08-01

Similar Documents

Publication Publication Date Title
IT1241395B (it) Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
Seia et al. Different roles of D‐amino acids in immune phenomena
Adam et al. Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers
EP3390440B1 (en) C-terminal lysine conjugated immunoglobulins
TWI237022B (en) Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
AU2020210919B2 (en) Glycoside-containing peptide linkers for antibody-drug conjugates
MX342788B (es) Proceso para la concentración de anticuerpos y productos terapéuticos de los mismos.
KR860004081A (ko) 폴리펩티드의 제조방법
CN1901839A (zh) 可溶性tcr分子及其用途
CA2420350A1 (en) Membrane penetrating peptides and uses thereof
US20200002409A1 (en) Compositions and methods for the removal of biofilms
BR112021001992A2 (pt) efeito adjuvante do agonista tlr1/2 diprovocim sinergiza com anticorpos inibidores de checkpoint para eliminar doença
AU7748801A (en) Prochelators for the preparation of radiometal labeled molecules having improvedbiological properties
CA2554195A1 (en) Peptide originating in epidermal growth factor receptor (egfr)
CA2003211A1 (en) Monoclonal antibodies
FI95273C (fi) Menetelmä kipua lievittävien peptidien, niiden amidien ja suolojen valmistamiseksi
DE69014150D1 (de) Immunogen-Verbindungen und deren Benutzung in der Herstellung von genetisch unbeschränkten synthetischen Impfstoffen und bei der immunoenzymatischer Bestimmung von antisporozoiden Antikörpern von Plasmodium malariae.
JP2013177378A (ja) 芳香族アミノ基を有する非天然アミノ酸を導入したタンパク質の部位特異的な修飾方法
Yamauchi Intramolecular ligand-ligand interactions in mixed ligand complexes
IT1241081B (it) Composti immunogenici e loro impiego per la preparazione di vaccini sintetici geneticamente non ristretti per la determinazione immunoenzimatica di anticorpi anti-sporozoita di plasmodium malariae
Young et al. The binding of analogs of phosphorylcholine by the murine myeloma proteins McPC 603, MOPC 167 and S107
US20250367166A1 (en) Next generation diprovocims that activate the innate and adaptive immune response
WO2020096775A1 (en) Sulfatase-cleavable linkers for antibody-drug conjugates
JPWO2004032966A1 (ja) 細胞増殖抑制剤
CA2289110A1 (fr) Analogues peptidiques et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970415